• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • NMPA Publishes 6 Regulatory Drafts Concerning Clinical Trials for Medical Devices and IVDs

NMPA Publishes 6 Regulatory Drafts Concerning Clinical Trials for Medical Devices and IVDs

Thursday, 27 May 2021 / Published in Medical Device, News, NMPA Registration in China

NMPA Publishes 6 Regulatory Drafts Concerning Clinical Trials for Medical Devices and IVDs

On May 10, 2021, the NMPA (National Medical Products Administration) published 6 regulatory draft documents concerning clinical trials for medical devices and IVDs:

  • Medical device clinical trial protocol template (Draft)
  • Medical device clinical trial report template (Draft)
  • In vitro diagnostic reagent clinical trial protocol template (Draft)
  • In vitro diagnostic reagent clinical trial report template (Draft)
  • Sample report form for serious adverse events in clinical trials of medical devices/in vitro diagnostic reagents (Draft)
  • Basic catalogue documents for clinical trials of medical devices (Draft)

The NMPA is currently soliciting public comments on the draft documents. The public consultation period is open until May 30, 2021.

Highlights

  • Covers the unified clinical trial test protocols and report format of IVD reagents
  • Heavily focuses on the procedures and requirements for reporting adverse events during clinical trials
  • Formulate a standardized directory using the data traceability of clinical trials
  • Identify items for improvements and blind spots from previous clinical trials, and propose actions to improve

By Jacky Li and Colleen Xu. Contact Cisema if you would like to learn more.

Tagged under: Clinical Trials, IVDs

What you can read next

New NMPA Guidelines on Periodic Risk Evaluation Reports (PRER) for Medical Device Adverse Events
Extensive Update of the Implementation Rules for the CCC Certification of Automotive Parts
Cross Border E-Commerce (CBEC): 24 New Zones and New List of Retail Imported Commodities

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Children cosmetics technical guidelines in China

    Children cosmetics technical guidelines in China – Newly issued by NIFDC

    Children cosmetics technical guidelines in Chin...
  • pH Determination Method

    China’s cosmetic safety technical specifications – 21 revision items issued

    China’s cosmetic safety technical specifi...
  • laser therapy devices

    Clinical evaluation of laser therapy devices – New guidelines issued

    Clinical evaluation of laser therapy devices ha...
  • dental implant system

    Clinical evaluation of dental implant systems in China – New guidelines issued

    Clinical evaluation of dental implant system ha...
  • China Medical Device Webinar

    China Medical Device Webinar with AdvaMed Accel for U.S. exporters

    The China Medical Device Webinar will be featur...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2003-2023 Cisema. All rights reserved.

TOP